Literature DB >> 9380402

MEK1 mediates a positive feedback on Raf-1 activity independently of Ras and Src.

S Zimmermann1, C Rommel, A Ziogas, J Lovric, K Moelling, G Radziwill.   

Abstract

Growth factor stimulated receptor tyrosine kinases activate a protein kinase cascade via the serine/threonine protein kinase Raf-1. Direct upstream activators of Raf-1 are Ras and Src. This study shows that MEK1, the direct downstream effector of Raf-1, can also stimulate Raf-1 kinase activity by a positive feedback loop. Activated MEK1 mediates hyperphosphorylation of the amino terminal regulatory as well as of the carboxy terminal catalytic domain of Raf-1. The hyperphosphorylation of Raf-1 correlates with a change in the tryptic phosphopeptide pattern only at the carboxy terminus of Raf-1 and an increase in Raf-1 kinase activity. MEK1-mediated Raf-1 activation is inhibited by co-expression of the MAPK specific phosphatase MKP-1 indicating that the MEK1 effect is exerted through a MAPK dependent pathway. Stimulation of Raf-1 activity by MEK1 is independent of Ras, Src and tyrosine phosphorylation of Raf-1. MEK1 can however synergize with Ras and leads to further increase of the Raf-1 kinase activity. Thus, MEK1 can mediate activation of Raf-1 by a novel positive feedback mechanism which allows fast signal amplification and could prolong activation of Raf-1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9380402     DOI: 10.1038/sj.onc.1201322

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Inhibition of Raf-1 alters multiple downstream pathways to induce pancreatic beta-cell apoptosis.

Authors:  Emilyn U Alejandro; James D Johnson
Journal:  J Biol Chem       Date:  2007-11-15       Impact factor: 5.157

2.  Identification of Raf-1 S471 as a novel phosphorylation site critical for Raf-1 and B-Raf kinase activities and for MEK binding.

Authors:  Jun Zhu; Vitaly Balan; Agnieszka Bronisz; Karina Balan; Hengrui Sun; Deborah T Leicht; Zhijun Luo; Jun Qin; Joseph Avruch; Guri Tzivion
Journal:  Mol Biol Cell       Date:  2005-08-10       Impact factor: 4.138

3.  HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction.

Authors:  Slava Rom; Marco Pacifici; Giovanni Passiatore; Susanna Aprea; Agnieszka Waligorska; Luis Del Valle; Francesca Peruzzi
Journal:  Biochim Biophys Acta       Date:  2011-07-01

4.  Retinoic acid increases amount of phosphorylated RAF; ectopic expression of cFMS reveals that retinoic acid-induced differentiation is more strongly dependent on ERK2 signaling than induced GO arrest is.

Authors:  A Yen; S Varvayanis
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-04       Impact factor: 2.416

5.  Identification of novel in vivo Raf-1 phosphorylation sites mediating positive feedback Raf-1 regulation by extracellular signal-regulated kinase.

Authors:  Vitaly Balan; Deborah T Leicht; Jun Zhu; Karina Balan; Alexander Kaplun; Vinita Singh-Gupta; Jun Qin; Hong Ruan; Michael J Comb; Guri Tzivion
Journal:  Mol Biol Cell       Date:  2006-01-11       Impact factor: 4.138

Review 6.  Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification.

Authors:  Karine Breckpot; David Escors
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2009-12       Impact factor: 2.895

7.  MEK-1 activates C-Raf through a Ras-independent mechanism.

Authors:  Deborah T Leicht; Vitaly Balan; Jun Zhu; Alexander Kaplun; Agnieszka Bronisz; Ajay Rana; Guri Tzivion
Journal:  Biochim Biophys Acta       Date:  2013-01-27

8.  Competing docking interactions can bring about bistability in the MAPK cascade.

Authors:  Stefan Legewie; Birgit Schoeberl; Nils Blüthgen; Hanspeter Herzel
Journal:  Biophys J       Date:  2007-05-25       Impact factor: 4.033

9.  Development of Highly Sensitive Biosensors of RAF Dimerization in Cells.

Authors:  Kyoko Miyamoto; Masaaki Sawa
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.